Title |
Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses
|
---|---|
Published in |
European Respiratory Journal, October 2012
|
DOI | 10.1183/09031936.00057112 |
Pubmed ID | |
Authors |
Liesbeth M. Kager, J. Daan de Boer, Paul Bresser, Jaring S. van der Zee, Sacha Zeerleder, Joost C.M. Meijers, Cornelis van 't Veer, Tom van der Poll |
Abstract |
Intravenous administration of activated protein C (APC) inhibits coagulation and inflammation in the lungs of humans and animals. Investigations in rodents demonstrated that direct intrapulmonary delivery of APC also exerts anticoagulant and anti-inflammatory effects. The effect of intrabronchial administration of recombinant human (rh)APC on lipopolysaccharide (LPS)-induced haemostatic and inflammatory alterations in the bronchoalveolar space of humans was studied. Eight subjects received rhAPC via intrabronchial instillation by bronchoscope, while in a contralateral subsegment subjects received saline; all subjects were challenged bilaterally with LPS in the same lung subsegments. Four additional subjects received rhAPC (75 μg), with saline as a control in the contralateral subsegment, while they were bilaterally "challenged" with saline. After 6 h a bronchoalveolar lavage was performed and coagulation and inflammatory parameters were measured. rhAPC enhanced LPS-induced coagulation activation in the bronchoalveolar space, when compared with the control side. In addition, rhAPC amplified LPS-induced pro-inflammatory responses, as indicated by higher concentrations of cytokines and chemokines. rhAPC alone did not have procoagulant or pro-inflammatory effects. Locally administered rhAPC has unexpected procoagulant and pro-inflammatory effects in LPS-challenged lung subsegments. These data argue against a role for intrapulmonary delivery of rhAPC as a treatment strategy for lung inflammatory disorders in humans. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 5% |
Unknown | 19 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor | 3 | 15% |
Student > Doctoral Student | 2 | 10% |
Student > Ph. D. Student | 2 | 10% |
Researcher | 2 | 10% |
Professor > Associate Professor | 2 | 10% |
Other | 5 | 25% |
Unknown | 4 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 35% |
Biochemistry, Genetics and Molecular Biology | 3 | 15% |
Agricultural and Biological Sciences | 3 | 15% |
Immunology and Microbiology | 1 | 5% |
Unknown | 6 | 30% |